Research advancing Kentucky: Revealing diabetes risks
Researchers at the University of Kentucky play an important role in advancing the health, well-being and future of our Commonwealth.
Much of that work is done with support from the National Institutes of Health (NIH). That support allows our researchers to find answers to many of the critical health issues facing Kentuckians.
Philip Kern, M.D., is supported by the National Institute on Aging, the National Institute of Arthritis Musculoskeletal and Skin Diseases, the National Institute of Environmental Health Sciences, the National Institute on Drug Abuse, the National Institute of Diabetes and Digestive and Kidney Diseases, and the National Center for Advancing Translational Sciences.
Kern is a professor of endocrinology in the Department of Internal Medicine in the UK College of Medicine. He’s co-director of the UK Center for Clinical and Translational Science (CCTS) and is clinical and research faculty in the UK Barnstable Brown Diabetes Center.
His research involves understanding fundamental molecular causes of diabetes. Kern also works to find new solutions to the problems and better determine who is at risk for diabetes and why.
“I could not perform my research without the infrastructure provided by many centers at UK, in particular the CCTS, where I perform studies with human participants, the Barnstable Brown Diabetes Center, and all the infrastructure provided through the Office of the Vice President for Research. This infrastructure includes people with specialized skills who would not be at UK if not for this supportive structure,” said Kern.
Kern and other members of the research community shared the importance of NIH-funded research at UK in this video series from Research Communications.
Learn more about each featured researcher.
Research in the news:
